Nissan Chemical Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Nissan Chemical ha un patrimonio netto totale di ¥227.1B e un debito totale di ¥57.4B, che porta il suo rapporto debito/patrimonio netto a 25.3%. Le sue attività totali e le sue passività totali sono rispettivamente ¥335.8B e ¥108.7B. L'EBIT di Nissan Chemical è ¥47.6B rendendo il suo rapporto di copertura degli interessi -43.9. Ha liquidità e investimenti a breve termine pari a ¥33.8B.

Informazioni chiave

25.3%

Rapporto debito/patrimonio netto

JP¥57.35b

Debito

Indice di copertura degli interessi	-43.9x
Contanti	JP¥33.77b
Patrimonio netto	JP¥227.09b
Totale passività	JP¥108.71b
Totale attività	JP¥335.80b

Aggiornamenti recenti sulla salute finanziaria

We Think Nissan Chemical (TSE:4021) Can Stay On Top Of Its Debt

Aug 27

Recent updates

Many Would Be Envious Of Nissan Chemical's (TSE:4021) Excellent Returns On Capital

Jul 11

Nissan Chemical (TSE:4021) Has Announced A Dividend Of ¥70.00

Jul 11

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( ¥212.2B ) di 4021 superano le sue passività a breve termine ( ¥92.0B ).

Passività a lungo termine: Le attività a breve termine di 4021 ( ¥212.2B ) superano le sue passività a lungo termine ( ¥16.7B ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 10.4% ) di 4021 è considerato soddisfacente.

Riduzione del debito: Il rapporto debito/patrimonio netto di 4021 è aumentato da 5.1% a 25.3% negli ultimi 5 anni.

Copertura del debito: Il debito di 4021 è ben coperto dal flusso di cassa operativo ( 64.1% ).

Copertura degli interessi: 4021 matura più interessi di quanti ne paga, quindi la copertura dei pagamenti degli interessi non è un problema.

Nissan Chemical Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

We Think Nissan Chemical (TSE:4021) Can Stay On Top Of Its Debt

Recent updates

Capital Investment Trends At Nissan Chemical (TSE:4021) Look Strong

Upcoming dividend of JP¥70.00 per share

Nissan Chemical (TSE:4021) Will Pay A Dividend Of ¥70.00

We Think Nissan Chemical (TSE:4021) Can Stay On Top Of Its Debt

First quarter 2025 earnings: EPS and revenues exceed analyst expectations

Nissan Chemical's (TSE:4021) Dividend Will Be ¥70.00

Nissan Chemical Corporation to Report Q2, 2025 Results on Nov 11, 2024

Investor sentiment deteriorates as stock falls 15%

Nissan Chemical (TSE:4021) Will Pay A Dividend Of ¥70.00

Many Would Be Envious Of Nissan Chemical's (TSE:4021) Excellent Returns On Capital

Nissan Chemical (TSE:4021) Has Announced A Dividend Of ¥70.00

Final dividend of JP¥70.00 announced

Full year 2024 earnings: Revenues and EPS in line with analyst expectations

Nissan Chemical Corporation to Report Q1, 2025 Results on Aug 09, 2024

Less than half of directors are independent

Nissan Chemical Corporation Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024

Price target decreased by 7.4% to JP¥6,401

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Nissan Chemical Corporation to Report Q3, 2024 Results on Feb 09, 2024

Upcoming dividend of JP¥70.00 per share at 2.5% yield

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Nissan Chemical Corporation to Report Q2, 2024 Results on Nov 10, 2023

Nissan Chemical Corporation Provides Dividend Guidance for the Second Quarter and Year End of Fiscal Year Ending March 31, 2024

Full year 2023 earnings: EPS misses analyst expectations

Nissan Chemical Corporation (TSE:4021) announces an Equity Buyback for 1,250,000 shares, representing 0.89% for ¥5,000 million.

Nissan Chemical Corporation to Report Q1, 2024 Results on Aug 10, 2023

Upcoming dividend of JP¥94.00 per share at 2.7% yield

Third quarter 2023 earnings: EPS misses analyst expectations

Nissan Chemical Corporation to Report Fiscal Year 2023 Results on May 15, 2023

Nissan Chemical Corporation Provides Dividend Guidance for the Year Ending March 31, 2023

Less than half of directors are independent

Second quarter 2023 earnings: EPS misses analyst expectations

Second quarter 2023 earnings: EPS misses analyst expectations

Nissan Chemical Corporation to Report Q3, 2023 Results on Feb 10, 2023

Nissan Chemical Corporation to Report Q2, 2023 Results on Nov 11, 2022

Upcoming dividend of JP¥70.00 per share

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Nissan Chemical Corporation Revises Dividend Guidance for the Second Quarter Ending September 30, 2022 and Year Ending March 31, 2023

Investor sentiment deteriorated over the past week

Full year 2022 earnings: EPS exceeds analyst expectations

Nissan Chemical Corporation Provides Consolidated Earnings Guidance for the First Half and Fiscal Year Ending March 31, 2023

Nissan Chemical Corporation to Report Q1, 2023 Results on Aug 08, 2022

Less than half of directors are independent

Upcoming dividend of JP¥68.00 per share

Tokyo District Court Renders Judgment on the Patent Infringement Lawsuit Concerning Edirol Capsules Against Sawai Pharmaceutical Co., Ltd., Nichi- Iko Pharmaceutical Co., Ltd. and Nissan Chemical Corporation

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Nissan Chemical Corporation to Report Q4, 2022 Results on May 13, 2022

Second quarter 2022 earnings released: EPS JP¥52.18 (vs JP¥43.55 in 2Q 2021)

Upcoming dividend of JP¥48.00 per share

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS JP¥61.73 (vs JP¥52.37 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥232 (vs JP¥210 in FY 2020)

Nissan Chemical Corporation Announces Dividend for the Full Year Ended March 31, 2021, Payable on June 28, 2021; Provides Divided Guidance for the Second Quarter Ending March 31, 2022 and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2022

Upcoming dividend of JP¥52.00 per share

New 90-day low: JP¥5,710

Chugai Pharmaceutical Co., Ltd. Refiles Patent Infringement Lawsuit Concerning Edirol Capsules

Earnings beat expectations, revenue disappoints

Third quarter 2021 earnings released: EPS JP¥30.92 (vs JP¥20.64 in 3Q 2020)

Nissan Chemical Corporation to Report Fiscal Year 2021 Results on May 14, 2021

New 90-day high: JP¥6,480

Chugai Pharmaceutical Co., Ltd. Files Patent Infringement Lawsuit Against Nissan Chemical Corporation, Sawai Pharmaceutical Co., Ltd. and Nichi-Iko Pharmaceutical Co., Ltd

Nissan Chemical Corporation to Report Q3, 2021 Results on Feb 05, 2021

Nissan Chemical Corporation to Report Q2, 2021 Results on Nov 12, 2020

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane